位置:首页 > 蛋白库 > WDR5_MOUSE
WDR5_MOUSE
ID   WDR5_MOUSE              Reviewed;         334 AA.
AC   P61965; Q91VA5; Q922C9; Q9NWX7; Q9UGP9;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 1.
DT   03-AUG-2022, entry version 165.
DE   RecName: Full=WD repeat-containing protein 5;
DE   AltName: Full=BMP2-induced 3-kb gene protein;
DE   AltName: Full=WD repeat-containing protein BIG-3;
GN   Name=Wdr5; Synonyms=Big, Big3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   STRAIN=C57BL/6J;
RX   PubMed=11551928; DOI=10.1074/jbc.m105757200;
RA   Gori F., Divieti P., Demay M.B.;
RT   "Cloning and characterization of a novel WD-40 repeat protein that
RT   dramatically accelerates osteoblastic differentiation.";
RL   J. Biol. Chem. 276:46515-46522(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Embryonic stem cell;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=Czech II, and FVB/N;
RC   TISSUE=Liver, Mammary tumor, and Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=15860628; DOI=10.1126/science.1107373;
RA   Brown S.A., Ripperger J., Kadener S., Fleury-Olela F., Vilbois F.,
RA   Rosbash M., Schibler U.;
RT   "PERIOD1-associated proteins modulate the negative limb of the mammalian
RT   circadian oscillator.";
RL   Science 308:693-696(2005).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brown adipose tissue, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   IDENTIFICATION IN THE MLL COMPLEX, AND INTERACTION WITH ASH2L; DPY30;
RP   KMT2A; KMT2D AND RBBP5.
RX   PubMed=21335234; DOI=10.1016/j.cell.2011.01.020;
RA   Jiang H., Shukla A., Wang X., Chen W.Y., Bernstein B.E., Roeder R.G.;
RT   "Role for Dpy-30 in ES cell-fate specification by regulation of H3K4
RT   methylation within bivalent domains.";
RL   Cell 144:513-525(2011).
RN   [7]
RP   INTERACTION WITH ZNF335.
RX   PubMed=23178126; DOI=10.1016/j.cell.2012.10.043;
RA   Yang Y.J., Baltus A.E., Mathew R.S., Murphy E.A., Evrony G.D.,
RA   Gonzalez D.M., Wang E.P., Marshall-Walker C.A., Barry B.J., Murn J.,
RA   Tatarakis A., Mahajan M.A., Samuels H.H., Shi Y., Golden J.A., Mahajnah M.,
RA   Shenhav R., Walsh C.A.;
RT   "Microcephaly gene links trithorax and REST/NRSF to control neural stem
RT   cell proliferation and differentiation.";
RL   Cell 151:1097-1112(2012).
RN   [8]
RP   INTERACTION WITH PAXBP1.
RX   PubMed=22862948; DOI=10.1016/j.stem.2012.05.022;
RA   Diao Y., Guo X., Li Y., Sun K., Lu L., Jiang L., Fu X., Zhu H., Sun H.,
RA   Wang H., Wu Z.;
RT   "Pax3/7BP is a Pax7- and Pax3-binding protein that regulates the
RT   proliferation of muscle precursor cells by an epigenetic mechanism.";
RL   Cell Stem Cell 11:231-241(2012).
CC   -!- FUNCTION: Contributes to histone modification (By similarity). May
CC       position the N-terminus of histone H3 for efficient trimethylation at
CC       'Lys-4' (By similarity). As part of the MLL1/MLL complex it is involved
CC       in methylation and dimethylation at 'Lys-4' of histone H3 (By
CC       similarity). H3 'Lys-4' methylation represents a specific tag for
CC       epigenetic transcriptional activation (By similarity). As part of the
CC       NSL complex it may be involved in acetylation of nucleosomal histone H4
CC       on several lysine residues (By similarity). May regulate osteoblasts
CC       differentiation (PubMed:11551928). In association with RBBP5 and ASH2L,
CC       stimulates the histone methyltransferase activities of KMT2A, KMT2B,
CC       KMT2C, KMT2D, SETD1A and SETD1B (By similarity).
CC       {ECO:0000250|UniProtKB:P61964, ECO:0000269|PubMed:11551928}.
CC   -!- SUBUNIT: Interacts with PAXBP1; the interaction is direct and links a
CC       WDR5-containing histone methyltransferase complex to PAX7 and PAX3
CC       (PubMed:22862948). Interacts with HCFC1 (By similarity). Component of
CC       the ATAC complex, a complex with histone acetyltransferase activity on
CC       histones H3 and H4 (By similarity). Component of the SET1 complex, at
CC       least composed of the catalytic subunit (SETD1A or SETD1B), WDR5,
CC       WDR82, RBBP5, ASH2L/ASH2, CXXC1/CFP1, HCFC1 and DPY30 (By similarity).
CC       Core component of several methyltransferase-containing complexes
CC       including MLL1/MLL, MLL2/3 (also named ASCOM complex) and MLL4/WBP7
CC       (PubMed:21335234). Each complex is at least composed of ASH2L, RBBP5,
CC       WDR5, DPY30, one or more specific histone methyltransferases
CC       (KMT2A/MLL1, KMT2D/MLL2, KMT2C/MLL3 and KMT2B/MLL4), and the
CC       facultative components PAGR1, BAP18, CHD8, E2F6, HCFC1, HCFC2, HSP70,
CC       INO80C, KDM6A, KANSL1, LAS1L, MAX, MCRS1, MEN1, MGA, MYST1/MOF, NCOA6,
CC       PAXIP1/PTIP, PELP1, PHF20, PRP31, RING2, RUVB1/TIP49A, RUVB2/TIP49B,
CC       SENP3, TAF1, TAF4, TAF6, TAF7, TAF9, TEX10 and alpha- and beta-tubulin
CC       (PubMed:21335234). Component of the NSL complex at least composed of
CC       MOF/KAT8, KANSL1, KANSL2, KANSL3, MCRS1, PHF20, OGT1/OGT, WDR5 and
CC       HCFC1 (By similarity). Interacts with KMT2A/MLL1 (via WIN motif) and
CC       RBBP5; the interaction is direct (By similarity). Component ofthe
CC       ADA2A-containing complex (ATAC), composed of KAT14, KAT2A, TADA2L,
CC       TADA3L, ZZ3, MBIP, WDR5, YEATS2, CCDC101 and DR1 (By similarity). In
CC       the complex, it probably interacts directly with KAT2A, MBIP and KAT14
CC       (By similarity). Interacts with histone H3 (By similarity). Interacts
CC       with SETD1A (via WIN motif) (By similarity). Component of a histone
CC       methylation complex composed of at least ZNF335, RBBP5, ASH2L and WDR5;
CC       the complex may have histone H3-specific methyltransferase activity,
CC       however does not have specificity for 'Lys-4' of histone H3 (By
CC       similarity). Interacts with ZNF335 (PubMed:23178126). Components of
CC       this complex may associate with components of the ZNF335-CCAR2-EMSY
CC       nuclear receptor-mediated transcription complex to form a complex at
CC       least composed of ZNF335, HCFC1, CCAR2, EMSY, MKI67, RBBP5, ASH2L and
CC       WDR5 (By similarity). Interacts with PER1 (By similarity). Interacts
CC       with KMT2D (via WIN motif) (PubMed:21335234). Interacts with KMT2B (via
CC       WIN motif), KMT2C (via WIN motif) and SETD1B (via WIN motif) (By
CC       similarity). {ECO:0000250|UniProtKB:P61964,
CC       ECO:0000250|UniProtKB:Q498M4, ECO:0000269|PubMed:21335234,
CC       ECO:0000269|PubMed:22862948, ECO:0000269|PubMed:23178126}.
CC   -!- INTERACTION:
CC       P61965; P20263: Pou5f1; NbExp=7; IntAct=EBI-1247084, EBI-1606219;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15860628}.
CC   -!- TISSUE SPECIFICITY: Expressed in liver (at protein level). Detected in
CC       brain, testis and kidney. {ECO:0000269|PubMed:15860628}.
CC   -!- SIMILARITY: Belongs to the WD repeat WDR5/wds family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF416510; AAL27006.1; -; mRNA.
DR   EMBL; AK075937; BAC36067.1; -; mRNA.
DR   EMBL; BC008547; AAH08547.1; -; mRNA.
DR   EMBL; BC016103; AAH16103.1; -; mRNA.
DR   EMBL; BC025801; AAH25801.1; -; mRNA.
DR   CCDS; CCDS15829.1; -.
DR   RefSeq; NP_543124.1; NM_080848.2.
DR   RefSeq; XP_006497735.1; XM_006497672.3.
DR   PDB; 2XL2; X-ray; 2.40 A; A/B=1-334.
DR   PDB; 2XL3; X-ray; 2.70 A; A/B=1-334.
DR   PDBsum; 2XL2; -.
DR   PDBsum; 2XL3; -.
DR   AlphaFoldDB; P61965; -.
DR   SMR; P61965; -.
DR   BioGRID; 228326; 62.
DR   ComplexPortal; CPX-1025; GCN5-containing ATAC complex.
DR   ComplexPortal; CPX-1029; PCAF-containing ATAC complex.
DR   ComplexPortal; CPX-875; NSL histone acetyltransferase complex.
DR   CORUM; P61965; -.
DR   DIP; DIP-38618N; -.
DR   ELM; P61965; -.
DR   IntAct; P61965; 46.
DR   MINT; P61965; -.
DR   STRING; 10090.ENSMUSP00000109585; -.
DR   iPTMnet; P61965; -.
DR   PhosphoSitePlus; P61965; -.
DR   EPD; P61965; -.
DR   MaxQB; P61965; -.
DR   PaxDb; P61965; -.
DR   PeptideAtlas; P61965; -.
DR   PRIDE; P61965; -.
DR   ProteomicsDB; 299669; -.
DR   Antibodypedia; 31978; 441 antibodies from 42 providers.
DR   DNASU; 140858; -.
DR   Ensembl; ENSMUST00000113952; ENSMUSP00000109585; ENSMUSG00000026917.
DR   GeneID; 140858; -.
DR   KEGG; mmu:140858; -.
DR   UCSC; uc012bsw.2; mouse.
DR   CTD; 11091; -.
DR   MGI; MGI:2155884; Wdr5.
DR   VEuPathDB; HostDB:ENSMUSG00000026917; -.
DR   eggNOG; KOG0266; Eukaryota.
DR   GeneTree; ENSGT00940000154143; -.
DR   InParanoid; P61965; -.
DR   OMA; RLWNYHT; -.
DR   OrthoDB; 957291at2759; -.
DR   PhylomeDB; P61965; -.
DR   TreeFam; TF314125; -.
DR   Reactome; R-MMU-3214841; PKMTs methylate histone lysines.
DR   Reactome; R-MMU-3214847; HATs acetylate histones.
DR   Reactome; R-MMU-3214858; RMTs methylate histone arginines.
DR   Reactome; R-MMU-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-MMU-8951664; Neddylation.
DR   BioGRID-ORCS; 140858; 28 hits in 71 CRISPR screens.
DR   ChiTaRS; Wdr5; mouse.
DR   EvolutionaryTrace; P61965; -.
DR   PRO; PR:P61965; -.
DR   Proteomes; UP000000589; Chromosome 2.
DR   RNAct; P61965; protein.
DR   Bgee; ENSMUSG00000026917; Expressed in secondary oocyte and 250 other tissues.
DR   ExpressionAtlas; P61965; baseline and differential.
DR   Genevisible; P61965; MM.
DR   GO; GO:0140672; C:ATAC complex; IDA:ComplexPortal.
DR   GO; GO:0000123; C:histone acetyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0035097; C:histone methyltransferase complex; ISS:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IC:ComplexPortal.
DR   GO; GO:0071339; C:MLL1 complex; ISS:UniProtKB.
DR   GO; GO:0044665; C:MLL1/2 complex; ISO:MGI.
DR   GO; GO:0044666; C:MLL3/4 complex; ISO:MGI.
DR   GO; GO:0044545; C:NSL complex; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048188; C:Set1C/COMPASS complex; ISS:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0042800; F:histone methyltransferase activity (H3-K4 specific); ISO:MGI.
DR   GO; GO:0035064; F:methylated histone binding; ISS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0006094; P:gluconeogenesis; IGI:MGI.
DR   GO; GO:0043966; P:histone H3 acetylation; ISO:MGI.
DR   GO; GO:0044154; P:histone H3-K14 acetylation; ISO:MGI.
DR   GO; GO:0051568; P:histone H3-K4 methylation; IMP:MGI.
DR   GO; GO:0043984; P:histone H4-K16 acetylation; ISS:UniProtKB.
DR   GO; GO:0043981; P:histone H4-K5 acetylation; ISS:UniProtKB.
DR   GO; GO:0043982; P:histone H4-K8 acetylation; ISS:UniProtKB.
DR   GO; GO:0051572; P:negative regulation of histone H3-K4 methylation; ISO:MGI.
DR   GO; GO:0031175; P:neuron projection development; ISO:MGI.
DR   GO; GO:0045722; P:positive regulation of gluconeogenesis; IGI:MGI.
DR   GO; GO:0051571; P:positive regulation of histone H3-K4 methylation; ISO:MGI.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IC:ComplexPortal.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:ComplexPortal.
DR   GO; GO:0051302; P:regulation of cell division; IDA:ComplexPortal.
DR   GO; GO:1900095; P:regulation of dosage compensation by inactivation of X chromosome; IDA:ComplexPortal.
DR   GO; GO:0045995; P:regulation of embryonic development; IDA:ComplexPortal.
DR   GO; GO:0031063; P:regulation of histone deacetylation; ISO:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; ISO:MGI.
DR   GO; GO:0090043; P:regulation of tubulin deacetylation; ISO:MGI.
DR   GO; GO:0001501; P:skeletal system development; IDA:MGI.
DR   Gene3D; 2.130.10.10; -; 1.
DR   IDEAL; IID50144; -.
DR   InterPro; IPR020472; G-protein_beta_WD-40_rep.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   InterPro; IPR036322; WD40_repeat_dom_sf.
DR   Pfam; PF00400; WD40; 7.
DR   PRINTS; PR00320; GPROTEINBRPT.
DR   SMART; SM00320; WD40; 7.
DR   SUPFAM; SSF50978; SSF50978; 1.
DR   PROSITE; PS00678; WD_REPEATS_1; 4.
DR   PROSITE; PS50082; WD_REPEATS_2; 6.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromatin regulator; Isopeptide bond; Nucleus;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; WD repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P61964"
FT   CHAIN           2..334
FT                   /note="WD repeat-containing protein 5"
FT                   /id="PRO_0000051351"
FT   REPEAT          43..82
FT                   /note="WD 1"
FT   REPEAT          85..126
FT                   /note="WD 2"
FT   REPEAT          128..168
FT                   /note="WD 3"
FT   REPEAT          169..208
FT                   /note="WD 4"
FT   REPEAT          212..253
FT                   /note="WD 5"
FT   REPEAT          256..296
FT                   /note="WD 6"
FT   REPEAT          299..333
FT                   /note="WD 7"
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        14..31
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            107
FT                   /note="Important for interaction with histone H3"
FT                   /evidence="ECO:0000250"
FT   SITE            133
FT                   /note="Important for interaction with histone H3"
FT                   /evidence="ECO:0000250"
FT   SITE            263
FT                   /note="Important for interaction with histone H3"
FT                   /evidence="ECO:0000250"
FT   SITE            322
FT                   /note="Important for interaction with histone H3"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P61964"
FT   MOD_RES         112
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P61964"
FT   CROSSLNK        7
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61964"
FT   CROSSLNK        27
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61964"
FT   CROSSLNK        46
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P61964"
FT   STRAND          36..41
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          48..53
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          57..64
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          69..73
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          79..83
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          90..95
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          99..106
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          109..115
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            116..119
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          120..126
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          132..137
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          142..148
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          153..157
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            158..160
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          163..167
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          174..179
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          183..190
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          195..199
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            200..203
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          204..209
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          217..222
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          226..233
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            234..236
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          237..242
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            243..246
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          247..252
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          258..260
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          264..267
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          269..271
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          273..276
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          283..287
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            288..290
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          293..297
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          304..309
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          311..320
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   TURN            322..324
FT                   /evidence="ECO:0007829|PDB:2XL2"
FT   STRAND          327..331
FT                   /evidence="ECO:0007829|PDB:2XL2"
SQ   SEQUENCE   334 AA;  36588 MW;  4BF30914A2250286 CRC64;
     MATEEKKPET EAARAQPTPS SSATQSKPTP VKPNYALKFT LAGHTKAVSS VKFSPNGEWL
     ASSSADKLIK IWGAYDGKFE KTISGHKLGI SDVAWSSDSN LLVSASDDKT LKIWDVSSGK
     CLKTLKGHSN YVFCCNFNPQ SNLIVSGSFD ESVRIWDVKT GKCLKTLPAH SDPVSAVHFN
     RDGSLIVSSS YDGLCRIWDT ASGQCLKTLI DDDNPPVSFV KFSPNGKYIL AATLDNTLKL
     WDYSKGKCLK TYTGHKNEKY CIFANFSVTG GKWIVSGSED NLVYIWNLQT KEIVQKLQGH
     TDVVISTACH PTENIIASAA LENDKTIKLW KSDC
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024